| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 16 |
| NetGPI | no | yes: 0, no: 16 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005739 | mitochondrion | 5 | 3 |
| GO:0005829 | cytosol | 2 | 3 |
| GO:0016020 | membrane | 2 | 10 |
| GO:0043226 | organelle | 2 | 3 |
| GO:0043227 | membrane-bounded organelle | 3 | 3 |
| GO:0043229 | intracellular organelle | 3 | 3 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
| GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: Q4QIY6
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 17 |
| GO:0004045 | aminoacyl-tRNA hydrolase activity | 5 | 17 |
| GO:0016787 | hydrolase activity | 2 | 17 |
| GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 17 |
| GO:0052689 | carboxylic ester hydrolase activity | 4 | 17 |
| GO:0140098 | catalytic activity, acting on RNA | 3 | 17 |
| GO:0140101 | catalytic activity, acting on a tRNA | 4 | 17 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 17 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 38 | 40 | PF00675 | 0.665 |
| CLV_NRD_NRD_1 | 70 | 72 | PF00675 | 0.435 |
| CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.265 |
| CLV_PCSK_KEX2_1 | 70 | 72 | PF00082 | 0.459 |
| CLV_PCSK_SKI1_1 | 157 | 161 | PF00082 | 0.265 |
| CLV_PCSK_SKI1_1 | 90 | 94 | PF00082 | 0.308 |
| CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.265 |
| CLV_Separin_Metazoa | 36 | 40 | PF03568 | 0.358 |
| DEG_APCC_DBOX_1 | 132 | 140 | PF00400 | 0.416 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.419 |
| DOC_PP4_FxxP_1 | 69 | 72 | PF00568 | 0.601 |
| DOC_USP7_MATH_1 | 123 | 127 | PF00917 | 0.561 |
| DOC_USP7_MATH_1 | 31 | 35 | PF00917 | 0.396 |
| DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.600 |
| DOC_WW_Pin1_4 | 9 | 14 | PF00397 | 0.493 |
| LIG_14-3-3_CanoR_1 | 77 | 83 | PF00244 | 0.679 |
| LIG_14-3-3_CanoR_1 | 9 | 13 | PF00244 | 0.405 |
| LIG_Actin_WH2_2 | 85 | 102 | PF00022 | 0.443 |
| LIG_BRCT_BRCA1_1 | 11 | 15 | PF00533 | 0.336 |
| LIG_BRCT_BRCA1_1 | 46 | 50 | PF00533 | 0.464 |
| LIG_FHA_1 | 213 | 219 | PF00498 | 0.518 |
| LIG_FHA_1 | 55 | 61 | PF00498 | 0.323 |
| LIG_FHA_2 | 31 | 37 | PF00498 | 0.366 |
| LIG_LIR_Apic_2 | 67 | 72 | PF02991 | 0.593 |
| LIG_LIR_Gen_1 | 14 | 23 | PF02991 | 0.399 |
| LIG_LIR_Nem_3 | 12 | 18 | PF02991 | 0.388 |
| LIG_OCRL_FandH_1 | 15 | 27 | PF00620 | 0.374 |
| LIG_Pex14_1 | 143 | 147 | PF04695 | 0.494 |
| LIG_Pex14_2 | 42 | 46 | PF04695 | 0.267 |
| LIG_SH2_STAP1 | 3 | 7 | PF00017 | 0.432 |
| LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.556 |
| LIG_SH3_3 | 175 | 181 | PF00018 | 0.479 |
| LIG_SH3_3 | 35 | 41 | PF00018 | 0.419 |
| LIG_SUMO_SIM_anti_2 | 57 | 62 | PF11976 | 0.262 |
| LIG_UBA3_1 | 168 | 173 | PF00899 | 0.520 |
| MOD_CDK_SPK_2 | 128 | 133 | PF00069 | 0.442 |
| MOD_CK1_1 | 11 | 17 | PF00069 | 0.498 |
| MOD_CK1_1 | 126 | 132 | PF00069 | 0.489 |
| MOD_CK1_1 | 153 | 159 | PF00069 | 0.520 |
| MOD_CK2_1 | 30 | 36 | PF00069 | 0.412 |
| MOD_CMANNOS | 143 | 146 | PF00535 | 0.286 |
| MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.378 |
| MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.351 |
| MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.243 |
| MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.687 |
| MOD_GSK3_1 | 124 | 131 | PF00069 | 0.515 |
| MOD_GSK3_1 | 50 | 57 | PF00069 | 0.317 |
| MOD_GSK3_1 | 78 | 85 | PF00069 | 0.646 |
| MOD_NEK2_1 | 124 | 129 | PF00069 | 0.511 |
| MOD_NEK2_1 | 50 | 55 | PF00069 | 0.323 |
| MOD_NEK2_1 | 64 | 69 | PF00069 | 0.594 |
| MOD_NEK2_1 | 99 | 104 | PF00069 | 0.553 |
| MOD_PIKK_1 | 188 | 194 | PF00454 | 0.455 |
| MOD_PKA_2 | 150 | 156 | PF00069 | 0.399 |
| MOD_PKA_2 | 8 | 14 | PF00069 | 0.402 |
| MOD_Plk_4 | 11 | 17 | PF00069 | 0.504 |
| MOD_Plk_4 | 196 | 202 | PF00069 | 0.458 |
| MOD_Plk_4 | 206 | 212 | PF00069 | 0.476 |
| MOD_Plk_4 | 50 | 56 | PF00069 | 0.392 |
| MOD_Plk_4 | 64 | 70 | PF00069 | 0.602 |
| MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.600 |
| MOD_ProDKin_1 | 9 | 15 | PF00069 | 0.493 |
| TRG_ER_diArg_1 | 69 | 71 | PF00400 | 0.662 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P574 | Leptomonas seymouri | 61% | 100% |
| A0A0N1IHT0 | Leptomonas seymouri | 33% | 92% |
| A0A1X0NKN2 | Trypanosomatidae | 47% | 100% |
| A0A1X0P1N6 | Trypanosomatidae | 29% | 85% |
| A0A3Q8IED2 | Leishmania donovani | 31% | 100% |
| A0A3R7N0D9 | Trypanosoma rangeli | 49% | 100% |
| A0A3S7WPI5 | Leishmania donovani | 90% | 100% |
| A4H4Q4 | Leishmania braziliensis | 76% | 100% |
| A4HIH3 | Leishmania braziliensis | 30% | 100% |
| A4I5S0 | Leishmania infantum | 31% | 100% |
| C9ZR39 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 86% |
| C9ZTL2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
| E9AKW9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
| E9B115 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
| Q4Q751 | Leishmania major | 30% | 100% |